-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 SaHz7uTO0vJcet1djM9ztMQzSm0L29+PQd6bTVmG+K0bOI3oo/tQ7hOVsPEdKI4p
 L7efA8yLasiaJXMl4reung==

<SEC-DOCUMENT>0001209191-06-000293.txt : 20060103
<SEC-HEADER>0001209191-06-000293.hdr.sgml : 20060102
<ACCEPTANCE-DATETIME>20060103154843
ACCESSION NUMBER:		0001209191-06-000293
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20060101
FILED AS OF DATE:		20060103
DATE AS OF CHANGE:		20060103

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			CALHOUN KIRK K
		CENTRAL INDEX KEY:			0001203721

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51445
		FILM NUMBER:		06502490

	BUSINESS ADDRESS:	
		STREET 1:		11777 SAN VICENTE BLVD
		STREET 2:		STE 530
		CITY:			WEST LOS ANGELES
		STATE:			CA
		ZIP:			90024
		BUSINESS PHONE:		3104704222

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adams Respiratory Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001319439
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				752725552
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		425 MAIN STREET
		CITY:			CHESTER
		STATE:			NJ
		ZIP:			07930
		BUSINESS PHONE:		(908) 879-1400

	MAIL ADDRESS:	
		STREET 1:		425 MAIN STREET
		CITY:			CHESTER
		STATE:			NJ
		ZIP:			07930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adams Laboratories, Inc.
		DATE OF NAME CHANGE:	20050302

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adams Respiratory Therapeutics, Inc.
		DATE OF NAME CHANGE:	20050301
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2006-01-01</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001319439</issuerCik>
        <issuerName>Adams Respiratory Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>ARXT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001203721</rptOwnerCik>
            <rptOwnerName>CALHOUN KIRK K</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>11777 SAN VICENTE BLVD</rptOwnerStreet1>
            <rptOwnerStreet2>STE 530</rptOwnerStreet2>
            <rptOwnerCity>WEST LOS ANGELES</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>90024</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2006-01-01</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>308</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.00</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>696</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The restricted units will vest in full on the first annual stockholders' meeting following the date of grant, or earlier in the case of certain terminations or change in control events.  Upon vesting, the restricted stock units will automatically convert into deferred stock units, which will not be converted into our common stock until six months following a director's termination of board service.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Brad Cole, Attorney-in-fact</signatureName>
        <signatureDate>2006-01-03</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----